1-1 of 1
Jayne E. Curry
Close
Sort by
Journal Articles

AT9283, a Potent Inhibitor of JAK2, Is Active in JAK2 V617F Myeloproliferative Disease Models.

Matthew S. Squires, PhD, Jayne E. Curry, Mark A. Dawson, Mike A. Scott, Kelly Barber, Matthias Reule, Tomoko Smyth, Nicola Wallis, Murray Yule, Neil T. Thompson, John F. Lyons, Anthony R. Green
Journal: Blood
Blood (2007) 110 (11): 3537.
https://doi.org/10.1182/blood.V110.11.3537.3537
Published: 2007